生殖医学杂志2026,Vol.35Issue(10):1229-1235,7.DOI:10.3969/j.issn.1004-3845.2026.10.004
945例女性绝经激素治疗方案选择和非预期出血分析
Analysis of menopausal hormone therapy regimen selection and unscheduled bleeding in 945 women
摘要
Abstract
Objectives:To analyze the selection of menopausal hormone therapy(MHT)regimens and the incidence of unscheduled bleeding in women with different years since menopause at MHT initiation,so as to provide references for clinicians applying MHT. Methods:Clinical data of 945 women who received MHT for ≥1 year at Department of Gynecological Endocrinology,Nanjing Women & Children's Healthcare Hospital from 2016 to 2023 were retrospectively analyzed.The women were divided into three groups according to the years since menopause when initiating MHT:<1 year group,1-<3 years group,and ≥3 years group.General information,indications for MHT,therapeutic regimens and adverse reactions of all included women were recorded.The relationship between initial MHT regimens and duration of amenorrhea,as well as the incidence and management strategies of unscheduled bleeding during treatment were analyzed. Results:The estrogen-progestogen sequential regimen was predominant in the<1 year group(705/718,98.19%).The estrogen-progestogen continuous combined regimen was the main regimen for the ≥3 years group(101/121,83.47%).In the 1-<3 years group,sequential regimens and continuous combined regimens accounted for 51.89%(55/106)and 48.11%(51/106),respectively.Unscheduled bleeding was the most common adverse reaction of MHT(158/945,16.72%),and the incidence differed significantly among women with different years since menopause at MHT initiation(x2=13.477,P=0.001).The incidence of unscheduled bleeding was significantly higher in the<1 year group than in other two groups(P<0.05),while no significant difference was found between the 1-<3 years group and ≥3 years group(P>0.05).Among all bleeding cases,96 occurred within 6 months after MHT initiation,all presenting as spotting,and the symptoms resolved after observation,medication adherence guidance,dose adjustment or regimen switching.The remaining 62 cases developed unscheduled bleeding after 6 months of MHT,all receiving transvaginal ultrasonography.Among them,24 patients with endometrial thickness>0.4 cm and heterogeneous echo underwent endometrial biopsy,and the pathological results revealed no endometrial atypical hyperplasia or malignancy;The other 38 patients with endometrial thickness ≤0.4 cm achieved resolved symptom via observation,dose modification or regimen adjustment. Conclusions:The choice of MHT regimens varied among women with different years since menopause at MHT initiation.The risk of endometrial malignancy was low in the women with unscheduled bleeding during MHT.Stratified management should be implemented according to the timing of bleeding:for bleeding occurring within 6 months of MHT initiation,special attention should be paid to missed or incorrect medication,and the bleeding of most cases resolved with observation,dose or regimen adjustment;for bleeding occurring more than 6 months after MHT initiation,transvaginal ultrasound assessment is required,and endometrial biopsy should be performed when indicated.关键词
绝经激素治疗/围绝经期/绝经/非预期出血Key words
Menopausal hormone therapy/Perimenopause/Menopause/Unscheduled bleeding分类
医药卫生引用本文复制引用
杨雨璇,陈捷,黄梦琪,秦鹏菲,孙艳丽,柏立琴..945例女性绝经激素治疗方案选择和非预期出血分析[J].生殖医学杂志,2026,35(10):1229-1235,7.基金项目
中国医药卫生事业发展基金会(BJ2023YCPYJH003) (BJ2023YCPYJH003)